Review



calcein am pi double staining kit  (Beyotime)


Bioz Verified Symbol Beyotime is a verified supplier
Bioz Manufacturer Symbol Beyotime manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Beyotime calcein am pi double staining kit
    Calcein Am Pi Double Staining Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 3114 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/Calcein+AM/pmc12926989-407-9-12
    Average 99 stars, based on 3114 article reviews
    calcein am pi double staining kit - by Bioz Stars, 2026-10
    99/100 stars

    Images

    Related Articles

    Labeling:

    Article Title: Rapamycin attenuates ferroptotic stress and improves macrophage efferocytosis in experimental atherosclerosis.
    Article Snippet: Background: Defective macrophage efferocytosis contributes to necrotic core formation and plaque instability in atherosclerosis.. Ferroptosis and mitochondrial dysfunction have been implicated in macrophage injury, but whether ferroptosis-associated mitochondrial dysfunction contributes to impaired efferocytosis and whether rapamycin can ameliorate these abnormalities remain unclear.. Objectives: This study aimed to investigate whether rapamycin improves macrophage efferocytosis under conditions of ferroptosis-associated mitochondrial dysfunction in atherosclerosis.

    Incubation:

    Article Title: Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.
    Article Snippet: .. Following the indicated treatments, cells were incubated with a staining solution containing 1 μL Calcein-AM and 1 μL propidium iodide (PI) in 1 mL DMEM/F12 medium for 30 min at 37 ◦C, according to the manufacturer's instructions for the Live/Dead Viability Assay Kit (Beyotime, Shanghai, China). ..

    Article Title: Bone Marrow Macrophage STING Signaling is a Direct Nexus Linking Marrow Adipose Expansion to NAD + Depletion and Osteogenic Decline in Skeletal Aging
    Article Snippet: Nuclei were then counterstained with DAPI for 2 min. All images were captured using a confocal laser scanning microscope (LSM 900, Zeiss, Germany). .. For the mPTP opening assay, cells were first incubated with MitoTracker Red (Beyotime, C1032) at 37°C for 30 min to visualize mitochondria, then stained with calcein‐AM solution (Beyotime, C2009) at 37°C for 30 min. ..

    Article Title: USP18/DDX5 axis ameliorates mitochondrial morphofunctional damage via OPA1 to inhibit neuronal apoptosis after traumatic brain injury.
    Article Snippet: .. Ten minutes later (i.e., at the end of the 30 min calcein-AM incubation), the staining was observed and images were captured under a fluorescence microscope (Cat #C542 Beyotime Biotechnology). .. Total RNA was isolated from mouse hippocampal tissues using TRIzol reagent combined with RNA-easy Isolation Reagent (Vazyme, China).

    Staining:

    Article Title: Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.
    Article Snippet: .. Following the indicated treatments, cells were incubated with a staining solution containing 1 μL Calcein-AM and 1 μL propidium iodide (PI) in 1 mL DMEM/F12 medium for 30 min at 37 ◦C, according to the manufacturer's instructions for the Live/Dead Viability Assay Kit (Beyotime, Shanghai, China). ..

    Article Title: Meningeal Lymphatic LTBR Deficiency Links Spinal Cord Injury to Secondary Brain Pathology
    Article Snippet: .. The cells were then stained with Calcein‐AM (C542, Beyotime, China) for 10 min at 37°C in the dark. ..

    Article Title: Engineering biomimetic coronary artery equivalents for Kawasaki disease modeling and drug screening.
    Article Snippet: .. For viability visualization, samples were stained with Calcein-AM and propidium iodide (PI; C1371S, Beyotime) for 30 min at 37 ◦C in the dark. .. Fluorescence images were captured using an inverted fluorescence microscope, and the live/dead cell ratio was quantified via ImageJ software.

    Article Title: Bone Marrow Macrophage STING Signaling is a Direct Nexus Linking Marrow Adipose Expansion to NAD + Depletion and Osteogenic Decline in Skeletal Aging
    Article Snippet: Nuclei were then counterstained with DAPI for 2 min. All images were captured using a confocal laser scanning microscope (LSM 900, Zeiss, Germany). .. For the mPTP opening assay, cells were first incubated with MitoTracker Red (Beyotime, C1032) at 37°C for 30 min to visualize mitochondria, then stained with calcein‐AM solution (Beyotime, C2009) at 37°C for 30 min. ..

    Article Title: Evaluation of PDA‑PLL Nanoparticles for siRNA Delivery and ROS Scavenging in Rat Osteoarthritis
    Article Snippet: .. Live/Dead Staining Assay The protective effects of PDA-PLL and PDA-PLL + TNF-α siRNA on OA chondrocytes were assessed with a CalceinAM/propidium iodide (PI) double-staining kit (Beyotime, China). ..

    Article Title: USP18/DDX5 axis ameliorates mitochondrial morphofunctional damage via OPA1 to inhibit neuronal apoptosis after traumatic brain injury.
    Article Snippet: .. Ten minutes later (i.e., at the end of the 30 min calcein-AM incubation), the staining was observed and images were captured under a fluorescence microscope (Cat #C542 Beyotime Biotechnology). .. Total RNA was isolated from mouse hippocampal tissues using TRIzol reagent combined with RNA-easy Isolation Reagent (Vazyme, China).

    Viability Assay:

    Article Title: Narirutin mitigates osteoarthritis by targeting USP15 to promote KEAP1 degradation and suppress chondrocyte ferroptosis.
    Article Snippet: .. Following the indicated treatments, cells were incubated with a staining solution containing 1 μL Calcein-AM and 1 μL propidium iodide (PI) in 1 mL DMEM/F12 medium for 30 min at 37 ◦C, according to the manufacturer's instructions for the Live/Dead Viability Assay Kit (Beyotime, Shanghai, China). ..

    ROS Assay:

    Article Title: GDNF-Enriched Small Extracellular Vesicle-Loaded ROS-Scavenging Hydrogel Promotes Neural Regeneration After Spinal Cord Injury.
    Article Snippet: .. Calcein-AM, Propidium Iodide (PI), a reactive oxygen species (ROS) assay kit, bicinchoninic acid (BCA) assay kit, and H2O2 content assay were purchased from Beyotime Inc. (Shanghai, China). .. A CCK-8 kit was purchased from Boster Biological Technology Co., Ltd (Wuhan, China).

    BIA-KA:

    Article Title: GDNF-Enriched Small Extracellular Vesicle-Loaded ROS-Scavenging Hydrogel Promotes Neural Regeneration After Spinal Cord Injury.
    Article Snippet: .. Calcein-AM, Propidium Iodide (PI), a reactive oxygen species (ROS) assay kit, bicinchoninic acid (BCA) assay kit, and H2O2 content assay were purchased from Beyotime Inc. (Shanghai, China). .. A CCK-8 kit was purchased from Boster Biological Technology Co., Ltd (Wuhan, China).

    Double Staining:

    Article Title: Evaluation of PDA‑PLL Nanoparticles for siRNA Delivery and ROS Scavenging in Rat Osteoarthritis
    Article Snippet: .. Live/Dead Staining Assay The protective effects of PDA-PLL and PDA-PLL + TNF-α siRNA on OA chondrocytes were assessed with a CalceinAM/propidium iodide (PI) double-staining kit (Beyotime, China). ..

    Fluorescence:

    Article Title: USP18/DDX5 axis ameliorates mitochondrial morphofunctional damage via OPA1 to inhibit neuronal apoptosis after traumatic brain injury.
    Article Snippet: .. Ten minutes later (i.e., at the end of the 30 min calcein-AM incubation), the staining was observed and images were captured under a fluorescence microscope (Cat #C542 Beyotime Biotechnology). .. Total RNA was isolated from mouse hippocampal tissues using TRIzol reagent combined with RNA-easy Isolation Reagent (Vazyme, China).

    Microscopy:

    Article Title: USP18/DDX5 axis ameliorates mitochondrial morphofunctional damage via OPA1 to inhibit neuronal apoptosis after traumatic brain injury.
    Article Snippet: .. Ten minutes later (i.e., at the end of the 30 min calcein-AM incubation), the staining was observed and images were captured under a fluorescence microscope (Cat #C542 Beyotime Biotechnology). .. Total RNA was isolated from mouse hippocampal tissues using TRIzol reagent combined with RNA-easy Isolation Reagent (Vazyme, China).



    Similar Products

    99
    Beyotime trichrome staining
    Trichrome Staining, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/Masson's+Trichrome+Staining+Kit/pm42862847-260-1-16
    Average 99 stars, based on 1 article reviews
    trichrome staining - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime hematoxylin
    Hematoxylin, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/Hematoxylin+and+Eosin+Staining+Kit/pmc13655258-279-0-11
    Average 99 stars, based on 1 article reviews
    hematoxylin - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime senescence associated β gal
    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) <t>and</t> <t>β-Gal</t> activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.
    Senescence Associated β Gal, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/Senescence+%CE%B2-Galactosidase+Staining+Kit/pmc13651863-271-5-10
    Average 99 stars, based on 1 article reviews
    senescence associated β gal - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    96
    Vector Laboratories immunohistochemistry ihc staining
    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) <t>and</t> <t>β-Gal</t> activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.
    Immunohistochemistry Ihc Staining, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/DAB+Peroxidase+(HRP)+Substrate+Kit+(with+Nickel)%2C+3%2C3%E2%80%99-diaminobenzidine/pm42855520-275-0-10
    Average 96 stars, based on 1 article reviews
    immunohistochemistry ihc staining - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    96
    Valiant Co Ltd 02195458 cf foxp3 transcription factor staining kit ebioscience 00 5523 00 paraformaldehyde
    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) <t>and</t> <t>β-Gal</t> activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.
    02195458 Cf Foxp3 Transcription Factor Staining Kit Ebioscience 00 5523 00 Paraformaldehyde, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/Paraformaldehyde/pm42855519-207-483-481
    Average 96 stars, based on 1 article reviews
    02195458 cf foxp3 transcription factor staining kit ebioscience 00 5523 00 paraformaldehyde - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    99
    Dojindo Labs ferroorange staining kit
    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) <t>and</t> <t>β-Gal</t> activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.
    Ferroorange Staining Kit, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/FerroOrange/10__1038_slash_s41598___026___74118___x-95-12-15
    Average 99 stars, based on 1 article reviews
    ferroorange staining kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Beyotime β galactosidase staining kit
    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) <t>and</t> <t>β-Gal</t> activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.
    β Galactosidase Staining Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/Lysosomal+%CE%B2-Galactosidase+Staining+Kit/pm42850481-105-31-34
    Average 99 stars, based on 1 article reviews
    β galactosidase staining kit - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec dapi staining solution
    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) <t>and</t> <t>β-Gal</t> activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.
    Dapi Staining Solution, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/staining+kit/MACSima+Stain+Support+Kit%2C+human/10__1038_slash_s42003___026___11109___8-243-16-19
    Average 94 stars, based on 1 article reviews
    dapi staining solution - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) and β-Gal activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.

    Journal: Science Advances

    Article Title: Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21

    doi: 10.1126/sciadv.aea2001

    Figure Lengend Snippet: ( A ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM). CCK8 assays reveal the cell growth under PAL (0.5 μM) or ABE (0.1 μM) treatment ( N = 3 biological replicates). ( B ) CCK8 assays calculating IC 50 values of SUV-ASO-Ms in MCF7-TAMR, MCF7-PALR, and MCF7-ABER cells ( N = 3 biological replicates). ( C ) Synergy Finder is calculating ZIP scores in MCF7-TAMR to study the synergistic effect between SUV-ASO-Ms and CDK4/6i (PAL and ABE). ( D and E ) MCF7-PALR and MCF7-ABER cells were treated with Ctr-ASO-M or SUV-ASO-Ms (0.1 μM) alone or in combination with CDK4/6i (PAL, 0.5 μM and ABE, 0.1 μM). Flow cytometry analysis (D) and β-Gal activity assays (20× magnification) (E) showing the cell cycle distribution and senescence of the cells. ( F ) Schematic depicting the experimental design of the MCF7-ABER xenograft tumors conducted to assess the efficacy of SUV-ASO2-M or a combination of SUV-ASO2-M with ABE in vivo. ( G to I ) After being treated with Ctr-ASO-M or SUV-ASO2-M in combination with Veh or ABE, the tumor growth curves (G), the harvested tumors (H), and the tumor weight (I) were measured. ( J and K ) RT-qPCR and Western blotting detection of SUV39H2 mRNA (J) and protein (K) in tumors from xenografts. ( L ) IHC staining of p21 in tumors from xenografts. H scores were calculated for p21 in all samples. Data were presented as means ± SD [(A to E), N = 3 biological replicates; (G), (I), (J) to (L), N = 5 biological replicates]. The P values were calculated by one-way ANOVA followed by Tukey’s test for multiple-group comparison.

    Article Snippet: Senescence was measured by the Senescence-Associated β-gal (SA-β-gal) Stain Kit (Beyotime, C0602).

    Techniques: Flow Cytometry, Analysis, Activity Assay, Xenograft Assay, In Vivo, Quantitative RT-PCR, Western Blot, Immunohistochemistry, Comparison

    ( A ) H3K9me3 signals (CUT&Tag) around promoters and enhancers in MCF7-ABER cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). ( B ) RAD21 signals (ChIP-seq) around enhancers in MCF7 cells ( GSE25021 and GSE72082 datasets). ( C ) RAD21 signals (ChIP-seq) around SUV39H2-dependent and independent H3K9me3 peaks. ( D ) A volcano plot of DEGs between the RAD21 overexpression and the control group (MCF7-ABER). ( E ) GSEA of transcriptome between RAD21 overexpression and the control. ( F and G ) Western blotting (F) and RT-qPCR (G) detection of RAD21 and p21 protein levels, and p21 mRNA levels in MCF7-PALR and MCF7-ABER cells with RAD21 overexpression. ( H ) IGV visualization of H3K9me3, RAD21, STAG1, and SMC1A signals in the p21 promoter ( p21 -Pro) and distal enhancer ( p21 -SE). Blue box: cohesin binding site; gray box: differential H3K9me3 peak. ( I and J ) ChIP-qPCR of H3K9me3 (I) and RAD21 (J) in p21 -Pro and p21 -SE of MCF7-PALR and MCF7-ABER cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). ( K ) ChIP-qPCR of SUV39H2 in p21 -Pro and p21 -SE of MCF7-PALR and MCF7-ABER cells. ( L ) Western blotting of RAD21, SUV39H2, and p21 protein levels in MCF7-ABER cells transfected with Ctr siRNA or RAD21 siRNA and then treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). ( M ) MCF7-ABER cells were transfected with Ctr siRNA or RAD21 siRNA1. CCK8 assays showing cell growth in cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM) in combination with ABE (0.1 μM). ( N ) MCF7-ABER cells were transfected with Ctr siRNA or RAD21 siRNA1. β-Gal activity assays (20× magnification) revealing the senescent cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). In (F), (G), (I) to (N), data were presented as means ± SD ( N = 3 biological replicates). The P values were calculated using a two-tailed unpaired Student’s t test for two-group comparison and one-way ANOVA followed by Tukey’s test for multiple-group comparisons.

    Journal: Science Advances

    Article Title: Targeting SUV39H2 exon skipping reverses resistance to CDK4/6 inhibitors via transcriptional activation of p21

    doi: 10.1126/sciadv.aea2001

    Figure Lengend Snippet: ( A ) H3K9me3 signals (CUT&Tag) around promoters and enhancers in MCF7-ABER cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). ( B ) RAD21 signals (ChIP-seq) around enhancers in MCF7 cells ( GSE25021 and GSE72082 datasets). ( C ) RAD21 signals (ChIP-seq) around SUV39H2-dependent and independent H3K9me3 peaks. ( D ) A volcano plot of DEGs between the RAD21 overexpression and the control group (MCF7-ABER). ( E ) GSEA of transcriptome between RAD21 overexpression and the control. ( F and G ) Western blotting (F) and RT-qPCR (G) detection of RAD21 and p21 protein levels, and p21 mRNA levels in MCF7-PALR and MCF7-ABER cells with RAD21 overexpression. ( H ) IGV visualization of H3K9me3, RAD21, STAG1, and SMC1A signals in the p21 promoter ( p21 -Pro) and distal enhancer ( p21 -SE). Blue box: cohesin binding site; gray box: differential H3K9me3 peak. ( I and J ) ChIP-qPCR of H3K9me3 (I) and RAD21 (J) in p21 -Pro and p21 -SE of MCF7-PALR and MCF7-ABER cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). ( K ) ChIP-qPCR of SUV39H2 in p21 -Pro and p21 -SE of MCF7-PALR and MCF7-ABER cells. ( L ) Western blotting of RAD21, SUV39H2, and p21 protein levels in MCF7-ABER cells transfected with Ctr siRNA or RAD21 siRNA and then treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). ( M ) MCF7-ABER cells were transfected with Ctr siRNA or RAD21 siRNA1. CCK8 assays showing cell growth in cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM) in combination with ABE (0.1 μM). ( N ) MCF7-ABER cells were transfected with Ctr siRNA or RAD21 siRNA1. β-Gal activity assays (20× magnification) revealing the senescent cells treated with Ctr-ASO-M or SUV-ASO2-M (0.1 μM). In (F), (G), (I) to (N), data were presented as means ± SD ( N = 3 biological replicates). The P values were calculated using a two-tailed unpaired Student’s t test for two-group comparison and one-way ANOVA followed by Tukey’s test for multiple-group comparisons.

    Article Snippet: Senescence was measured by the Senescence-Associated β-gal (SA-β-gal) Stain Kit (Beyotime, C0602).

    Techniques: ChIP-sequencing, Over Expression, Control, Western Blot, Quantitative RT-PCR, Binding Assay, ChIP-qPCR, Transfection, Activity Assay, Two Tailed Test, Comparison